Regent Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-42,473
Closed -$4.22M 217
2019
Q3
$4.22M Sell
42,473
-50
-0.1% -$4.75K 1.38% 16
2019
Q2
$3.93M Sell
42,523
-600
-1% -$57K 1.28% 18
2019
Q1
$4.07M Buy
43,123
+1,045
+2% +$91.4K 1.35% 16
2018
Q4
$2.7M Sell
42,078
-1,940
-4% -$143K 1.01% 26
2018
Q3
$3.94M Sell
44,018
-4,895
-10% -$433K 1.23% 19
2018
Q2
$3.88M Sell
48,913
-980
-2% -$81.4K 1.3% 17
2018
Q1
$4.45M Sell
49,893
-170
-0.3% -$16.3K 1.51% 15
2017
Q4
$5.22M Sell
50,063
-4,431
-8% -$500K 1.71% 12
2017
Q3
$7.95M Buy
54,494
+2,210
+4% +$301K 2.68% 4
2017
Q2
$6.79M Buy
52,284
+7,095
+16% +$869K 2.39% 5
2017
Q1
$5.62M Buy
45,189
+4,685
+12% +$561K 2.12% 8
2016
Q4
$4.69M Sell
40,504
-820
-2% -$91.3K 2.4% 7
2016
Q3
$4.32M Buy
41,324
+275
+0.7% +$29.8K 2.24% 8
2016
Q2
$4.05M Sell
41,049
-510
-1% -$52.8K 2.2% 8
2016
Q1
$4.16M Sell
41,559
-245
-0.6% -$25.2K 2.31% 7
2015
Q4
$5.01M Sell
41,804
-230
-0.5% -$26.6K 2.68% 5
2015
Q3
$4.55M Buy
42,034
+1,560
+4% +$194K 2.51% 6
2015
Q2
$4.68M Buy
40,474
+2,450
+6% +$280K 2.36% 8
2015
Q1
$4.38M Buy
38,024
+2,740
+8% +$327K 2.22% 6
2014
Q4
$3.95M Sell
35,284
-125
-0.4% -$13.2K 2.03% 10
2014
Q3
$3.36M Buy
35,409
+1,945
+6% +$176K 1.72% 12
2014
Q2
$2.87M Buy
33,464
+2,760
+9% +$210K 1.42% 17
2014
Q1
$2.14M Buy
30,704
+8,640
+39% +$684K 1.13% 24
2013
Q4
$1.86M Buy
22,064
+3,270
+17% +$259K 1.05% 30
2013
Q3
$1.45M Sell
18,794
-1,246
-6% -$87.3K 0.96% 33
2013
Q2
$1.17M Buy
+20,040
New +$1.21M 0.9% 36

Other funds holding CELG

Regent Investment Management's CELG Position: Q4 2019 in Review

Regent Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 42,473 shares — an estimated $4.22M sold.

Regent Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.95M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Regent Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Regent Investment Management sold 42,473 Celgene Corp shares in Q4 2019, an estimated $4.22M.
  • Regent Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Regent Investment Management's Celgene Corp position peaked at $7.95M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Regent Investment Management's 13F filing for Q4 2019, filed 30 Jan 2020.